Primary Article
Vascular Hamartomas and Hemangiomas Classification and Treatment
Abstract
Former classifications of hemangiomas and other congenital vascular anomalies have been confusing, inconsistent, and often unrelated to clinical prognosis. I propose a simplified classification of all vascular hamartomas. Primary involvement of the afferent versus the efferent sides of the fetal vascular tree appears to be correlated with the postnatal growth potential of these lesions, and this forms the basis for the new classification. Four relatively new and useful treatment technics are systemic steroid therapy, thrombin-Gelfoam embolism, laser therapy, and interstitial resection and reconstruction. Proper integration of these with older established treatment methods significantly reduces deformity and functional loss in most patients with vascular hamartomas.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.